Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
D. D. Ankola
Observed names:
Ankola, Dhawal Dhirajlal,
D D Ankola,
D.D. Ankola,
Dhawal D. Ankola
Institution:
University of Strathclyde
Observed institutions:
University of Strathclyde,
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research
OpenAlex ID:
A5088068161
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
2009
·
J. Shaikh
, D.D. Ankola
, et al.
·
European Journal of Pharmaceutical Sciences
·
983
Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective
2006
·
D. Venkat Ratnam
, D.D. Ankola
, et al.
·
Journal of Controlled Release
·
900
PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat
2009
·
V. Bhardwaj
, D. D. Ankola
, et al.
·
Pharmaceutical Research
·
146
Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?
2007
·
D.D. Ankola
, B. Viswanad
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
113
Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives
2010
·
C.N. Grama
, D.D. Ankola
, et al.
·
Current Opinion in Colloid & Interface Science
·
45
Nanoparticles Enhance Per Oral Bioavailability of Poorly Available Molecules: Epigallocatechin Gallate Nanoparticles Ameliorates Cyclosporine Induced Nephrotoxicity in Rats at Three Times Lower Dose Than Oral Solution
2008
·
J. L. Italia
, P. Datta
, et al.
·
Journal of Biomedical Nanotechnology
·
41
Oral Nanoparticulate Atorvastatin Calcium is More Efficient and Safe in Comparison to Lipicure® in Treating Hyperlipidemia
2008
·
A. K. Meena
, D. Venkat Ratnam
, et al.
·
Lipids
·
40
Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A
2010
·
D. D. Ankola
, A. Battisti
, et al.
·
Journal of The Royal Society Interface
·
23
Multiblock Copolymers of Lactic Acid and Ethylene Glycol Containing Periodic Side-Chain Carboxyl Groups: Synthesis, Characterization, and Nanoparticle Preparation
2009
·
Dhawal D. Ankola
, M. N. V. Ravi Kumar
, et al.
·
Macromolecules
·
17
Nanoparticulate Delivery Can Improve Peroral Bioavailability of Cyclosporine and Match Neoral Cmax Sparing the Kidney from Damage
2011
·
D. D. Ankola
, R. M. Wadsworth
, et al.
·
Journal of Biomedical Nanotechnology
·
16
Preparation, characterization andin silicomodeling of biodegradable nanoparticles containing cyclosporine A and coenzyme Q10
2010
·
D D Ankola
, E W Durbin
, et al.
·
Nanotechnology
·
14
Biodegradable nanoparticles for oral delivery of Ciclosporin
2010
·
Ankola, Dhawal Dhirajlal
·
OpenGrey (Institut de l'Information Scientifique et Technique)
Synthesis, degradation and nanoparticulate applications of carboxylated (ABA)n type block copolymers of lactic acid (A) and ethylene glycol (B) for drug delivery
2009
·
D. D. Ankola
, M. N. V. Ravi Kumar
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
AFM temperature study of PLLA-PEG-PLLA copolymer
2008
·
Michele Alderighi
, D. D. Ankola
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
Show more works
View as search
Works count:
14
Citation count:
2,338
H-index:
11
I10-index:
11
Year
Topic
Type